High Potency Pancreatin Pharmaceutical Compositions

Patent No. EP3003360 (titled "High Potency Pancreatin Pharmaceutical Compositions") was filed by Allergan Pharmaceuticals on Nov 5, 2014. The application was issued on Oct 7, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
CAMULON	Jul 6, 2021	ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Mar 5, 2024
Brief communication - Opposition proceedings
Mar 5, 2024
Brief communication - Opposition proceedings
Mar 5, 2024
Decision revoking the European patent
Mar 5, 2024
Decision revoking the European patent
Mar 1, 2024
Brief communication - Opposition proceedings
Feb 29, 2024
(Electronic) Receipt
Feb 29, 2024
Letter accompanying subsequently filed items
Feb 29, 2024
Request for revocation of patent
Oct 20, 2023
(Electronic) Receipt
Oct 20, 2023
Advice of delivery
Oct 20, 2023
Letter accompanying subsequently filed items
Oct 5, 2023
Advice of delivery
Oct 5, 2023
Annex to the communication - opposition
Oct 5, 2023
Information concerning oral proceedings
Oct 5, 2023
Scanned annex to a communication - opposition procedure
Oct 5, 2023
Summons to attend oral proceedings
Oct 5, 2023
Summons to attend oral proceedings
Oct 5, 2023
Transmittal of decision / summons - opposition
Oct 5, 2023
Transmittal of decision / summons - opposition
Jul 11, 2023
Brief communication - Opposition proceedings
Jul 6, 2023
(Electronic) Receipt
Jul 6, 2023
Letter accompanying subsequently filed items
Jul 6, 2023
Letter regarding the opposition procedure (no time limit)
May 12, 2023
(Electronic) Receipt
May 12, 2023
Request concerning the applicant/representative
May 8, 2023
Communication: patent lapsed
May 8, 2023
Communication: patent lapsed
Nov 22, 2022
Brief communication - Opposition proceedings
Nov 16, 2022
(Electronic) Receipt
Nov 16, 2022
General enquiry
Nov 16, 2022
Letter accompanying subsequently filed items
Mar 28, 2022
Brief communication - Opposition proceedings
Mar 16, 2022
Miscellaneous requests concerning client data
Mar 16, 2022
Request for change of applicant's representative
Dec 7, 2021
Brief communication - Opposition proceedings
Nov 30, 2021
(Electronic) Receipt
Nov 30, 2021
Auxiliary request during Opposition procedure
Nov 30, 2021
Auxiliary request during Opposition procedure - 01
Nov 30, 2021
Letter accompanying subsequently filed items
Nov 30, 2021
Reply of the patent proprietor to the notice(s) of opposition
Nov 30, 2021
Reply of the patent proprietor to the notice(s) of opposition
Sep 1, 2021
Request for change of applicant's representative
Jul 21, 2021
Communication of a notice of opposition and request to file observations
Jul 21, 2021
Notice of further oppositions to opponent(s)
Jul 12, 2021
Communication of a notice of opposition - first information to patent proprietor
Jul 6, 2021
(Electronic) Receipt
Jul 6, 2021
Citation in opposition procedure - 001
Jul 6, 2021
Citation in opposition procedure - 002
Jul 6, 2021
Citation in opposition procedure - 003
Jul 6, 2021
Citation in opposition procedure - 004
Jul 6, 2021
Citation in opposition procedure - 005
Jul 6, 2021
Citation in opposition procedure - 006
Jul 6, 2021
Consolidated list of cited opposition documents
Jul 6, 2021
Notice of opposition
Jul 6, 2021
Notice of opposition
Oct 19, 2020
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Sep 10, 2020
Decision to grant a European patent
Sep 7, 2020
Communication of the registration of a transfer or change of name and/or address
Sep 7, 2020
Rectification of the designation of the inventor under Rule 21 EPC
Aug 21, 2020
(Electronic) Receipt
Aug 21, 2020
Annexes in respect of a client data request
Aug 21, 2020
Letter accompanying subsequently filed items
Aug 21, 2020
Submission concerning a transfer of rights (applicant)
Jul 9, 2020
(Electronic) Receipt
Jul 9, 2020
Filing of the translations of the claims
Jul 9, 2020
French translation of claims
Jul 9, 2020
German translation of the claims
Jun 19, 2020
Indication of deficiencies in a request for registering a transfer of rights and invitation to correct them
Jun 2, 2020
(Electronic) Receipt
Jun 2, 2020
Annex
Jun 2, 2020
Annex
Jun 2, 2020
Annex
Jun 2, 2020
Annex
Jun 2, 2020
Annex
Jun 2, 2020
Annex
Jun 2, 2020
Annex
Jun 2, 2020
Annexes in respect of a client data request
Jun 2, 2020
Annexes in respect of a client data request
Jun 2, 2020
Letter accompanying subsequently filed items
Jun 2, 2020
Request for correction of errors in filed documents
Apr 3, 2020
Bibliographic data of the European patent application
Apr 3, 2020
Communication about intention to grant a European patent
Apr 3, 2020
Intention to grant (signatures)
Apr 3, 2020
Text intended for grant (clean copy)
Apr 3, 2020
Text intended for grant (version for approval)
Nov 5, 2019
(Electronic) Receipt
Nov 5, 2019
Amended claims with annotations
Nov 5, 2019
Amended description with annotations
Nov 5, 2019
Claims
Nov 5, 2019
Description
Nov 5, 2019
Letter accompanying subsequently filed items
Nov 5, 2019
Reply to communication from the Examining Division
Sep 24, 2019
Grant of extension of time limit (examination procedure)
Sep 17, 2019
(Electronic) Receipt
Sep 17, 2019
Request for extension of time limit to communication from the Examining Division
May 7, 2019
Annex to the communication
May 7, 2019
Communication from the Examining Division
Apr 8, 2019
Communication of the registration of a transfer or change of name and/or address
Mar 25, 2019
(Electronic) Receipt
Mar 25, 2019
Amended claims with annotations
Mar 25, 2019
Annexes in respect of a client data request
Mar 25, 2019
Claims
Mar 25, 2019
Letter accompanying subsequently filed items
Mar 25, 2019
Reply to communication from the Examining Division
Mar 25, 2019
Submission concerning change of applicant's name
Jan 25, 2019
Grant of extension of time limit (examination procedure)
Jan 18, 2019
(Electronic) Receipt
Jan 18, 2019
Request for extension of time limit to communication from the Examining Division
Sep 13, 2018
Annex to the communication
Sep 13, 2018
Communication from the Examining Division
Aug 20, 2018
Communication of amended entries concerning the representative
Aug 13, 2018
Submission concerning change of applicant's representative
Jun 14, 2018
(Electronic) Receipt
Jun 14, 2018
Amended claims with annotations
Jun 14, 2018
Claims
Jun 14, 2018
Letter accompanying subsequently filed items
Jun 14, 2018
Reply to communication from the Examining Division
Apr 11, 2018
Grant of extension of time limit (examination procedure)
Apr 5, 2018
(Electronic) Receipt
Apr 5, 2018
Letter accompanying subsequently filed items
Apr 5, 2018
Request for extension of time limit to communication from the Examining Division
Dec 4, 2017
Annex to the communication
Dec 4, 2017
Communication from the Examining Division
Nov 28, 2017
Examination started
Oct 16, 2017
(Electronic) Receipt
Oct 16, 2017
Amended claims filed after receipt of (European) search report
Oct 16, 2017
Amended claims with annotations
Oct 16, 2017
Amendments received before examination
Oct 16, 2017
Letter accompanying subsequently filed items
Sep 14, 2017
Submission concerning representation
Apr 11, 2017
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Mar 24, 2017
Communication regarding the transmission of the European search report
Mar 24, 2017
Document annexed to the Extended European Search Report
Mar 24, 2017
European search opinion
Mar 24, 2017
Information on Search Strategy
Mar 24, 2017
Supplementary European search report
Jan 18, 2017
(Electronic) Receipt
Jan 18, 2017
Letter accompanying subsequently filed items
Jan 18, 2017
Letter concerning search matters
Nov 14, 2016
Communication regarding the transmission of the European search report
Nov 14, 2016
Information on Search Strategy
Nov 14, 2016
Information on Search Strategy
Nov 14, 2016
Partial European search report
Oct 28, 2016
Search started
Aug 8, 2016
Invitation to indicate correct address of inventor
Jul 25, 2016
Letter which had not been notified
Jul 11, 2016
Invitation to indicate correct address of inventor
Jul 1, 2016
Letter which had not been notified
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
Jun 10, 2016
Communication to designated inventor
May 24, 2016
Copy of the international preliminary report on patentability
Mar 16, 2016
Notification on forthcoming publication of bibliographic data
Feb 24, 2016
(Electronic) Receipt
Feb 24, 2016
Amended claims filed after receipt of (European) search report
Feb 24, 2016
Amended claims with annotations
Feb 24, 2016
Amendments received before examination
Feb 24, 2016
Letter accompanying subsequently filed items
Jan 26, 2016
Communication regarding possible amendment of the application/payment of claims fee
Jan 7, 2016
(Electronic) Receipt
Jan 7, 2016
Amended claims filed after receipt of (European) search report
Jan 7, 2016
Amended claims with annotations
Jan 7, 2016
Amendments received before examination
Jan 7, 2016
Annex
Jan 7, 2016
Request for entry into the European phase
Jan 7, 2016
Submission concerning representation
Dec 23, 2015
Notification of the recording of a change
Jun 1, 2015
Priority document (electronically transmitted)
May 14, 2015
Copy of the international search report
May 14, 2015
Published international application - A1

EP3003360

ALLERGAN PHARMACEUTICALS

Application Number: EP14859866A
Filing Date: Nov 5, 2014
Status: Revoked; Mar 8, 2024
Publication Date: Oct 7, 2020
External Links: Slate, EP3003360B1, Google Patents

IP Verse

High Potency Pancreatin Pharmaceutical Compositions

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3003360